Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Makras P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al. Osteoporos Int 2023 Dec 26. doi: 10.1007/s00198-023-07000.

Read + Share

Amedeo Smart

Independent Medical Education

Makras P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al. Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment. Osteoporos Int 2023 Dec 26. doi: 10.1007/s00198-023-07000.
PMID: 38147135